Original Article

The safety and efficacy of transurethral microwave therapy in high-risk catheter-dependent men

Volume 45 · Issue 1 Publish Date: July 25, 2019
Full Text PDF
DOI
Theodore R. Saitz
Oregon Health and Science University, Portland, USA
Michael J. Conlin
Veterans Affairs Portland Health Care System, Portland, USA
Christopher D. Tessier
Veterans Affairs Portland Health Care System, Portland, USA
Thomas R. Hatch
Veterans Affairs Portland Health Care System, Portland, USA
Saitz, T. R., Conlin, M. J., Tessier, C. D., & Hatch, T. R. (2019). The safety and efficacy of transurethral microwave therapy in high-risk catheter-dependent men. Urology Research and Practice, 45(1), 27–30. https://doi.org/10.5152/tud.2018.09622
Full Text Full Text PDF

Abstract

Abstract

Objective: Previous studies have demonstrated the efficacy of transurethral microwave therapy (TUMT) in the management of high-risk catheter-dependent men, although few have assessed safety in high-risk patients, including those continuing anticoagulation therapy during treatment. Our goal was to assess the safety and effectiveness of TUMT in a population of high-risk catheter-dependent men.

Material and methods: A retrospective analysis of patients who underwent TUMT at a single Veterans Affairs facility for the treatment of benign prostatic hyperplasia was completed. The primary outcome was 30-day postprocedural complications by Clavien-Dindo grade, including bleeding events. The secondary outcome was success in catheter removal.

Results: We performed TUMT in 157 men, 105 of whom had urinary retention-requiring an indwelling urethral catheter or clean intermittent catheterization. Overall, 86% of patients underwent TUMT while on anticoagulant therapy and 25% were treated while taking warfarin. The median age of the patients was 76.9 years (95% CI 74.9-78.8) median ASA-score was 3, and median follow-up was 26 months (range 1-65). Only two men experienced hematuria requiring treatment postoperatively and no transfusions were required. Only two patients (1.9%) required readmission within 30 days after treatment. There were 24 (22.9%) Clavien-Dindo grade I-II complications without grade III or higher complications. Urinary retention resolved in 63.7% of men after treatment.

Conclusion: Our results suggest that TUMT is a safe and reasonably effective treatment for high-risk catheter-dependent men. Furthermore, the low incidence of adverse bleeding events suggests that TUMT is a safe treatment modality for men requiring uninterrupted anticoagulation.

Cite this article as: Saitz TR, Conlin MJ, Tessier CD, Hatch TR. The safety and efficacy of transurethral microwave therapy in high-risk catheter-dependent men. Turk J Urol 2019; 45(1): 27-30.

Similar Articles

Article Info
Published In
Journal Urology Research and Practice
Volume / Issue Volume 45 · Issue 1
Pages 27-30
History
Published Online July 25, 2019
Copyright
Affiliations
Theodore R. Saitz
Oregon Health and Science University, Portland, USA
Michael J. Conlin
Veterans Affairs Portland Health Care System, Portland, USA
Christopher D. Tessier
Veterans Affairs Portland Health Care System, Portland, USA
Thomas R. Hatch
Veterans Affairs Portland Health Care System, Portland, USA
Cite this Article
Saitz, T. R., Conlin, M. J., Tessier, C. D., & Hatch, T. R. (2019). The safety and efficacy of transurethral microwave therapy in high-risk catheter-dependent men. Urology Research and Practice, 45(1), 27–30. https://doi.org/10.5152/tud.2018.09622
Outlines